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ABSTRACT

The present study defines the expression pattern of rTAPA (CD81)
in the developing rat brain. rTAPA is a member of the tetramembrane
spanning family of proteins, and like other members of this family, appears
to be associated with the stabilization of cellular contacts. On
immunoblots of the brain, rTAPA is present in higher levels than any other
tissue examined: muscle, tendon, peripheral nerve, cartilage, liver, kidney,
skin, and testicle. Immunohistochemical methods were used to define the
distribution of rTAPA in the brain. This protein is expressed by ependyma,
choroid plexus, astrocytes, and oligodendrocytes, and rTAPA is
dramatically upregulated at the time of glial birth and maturation. At
embryonic day 18, the levels of rTAPA are low, with most of the
immunoreaction product associated with the ependyma, choroid plexus,
and the glia limitans. As development continues, the amount of rTAPA
expressed in the brain increases and at postnatal day 14 the levels
approach those of the adult. This increase of rTAPA at postnatal day 14 is
due to the upregulation in the gray and white matter. Thus, rTAPA is
found in all glial cells and the level of this protein correlates with their
maturation.
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CHAPTER 1. INTRODUCTION

Two major events in the final stages of central nervous system
(CNS) development are the birth and maturation of glia. Glial cells born
during this period form the majority of cells in the CNS and have a number
of different functions. Within the brain and spinal cord both microglia
(Flaris et al., 1993) and macroglia are present. This report focuses on the
different types of macroglia: astrocytes, oligodendrocytes, ependymal cells,
choroidal cells, and radial glia. The earliest generated glial cells are the
radial glia (Misson et al., 1991). These cells are specifically associated with
neuronal migration (Rakic, 1971; Caviness and Rakic, 1978; Hatten, 1990;
Misson et al., 1991; Komuro and Rakic, 1993). Shortly following the
emergence of the radial glia, the ependymal lining of the ventricular system
develops and the choroid plexus forms (for review see, Del Bigio, 1995).
The final populations of glial cells are born during the late embryonic
period and extending into early postnatal life, a time when neurogenesis is
ending (Ling and Leblond, 1973; Parnavelas et al., 1983). The majority of
these cells differentiate into astrocytes and oligodendrocytes.
The number of glia in the mammalian neocortex is much greater than
the number of neurons, particularly in larger brains. Many of the glia
colonizing the neocortex originate as immature cells of the subventricular
zone (Levison and Goldman, 1993; Zerlin et al., 1995). These cells migrate
to the neocortex and either differentiate into a terminal cell type, i.e.
astrocyte or oligodendrocyte, or continue to divide for a few generations
before differentiating. Unlike neurons, there is no evidence that there is a
laminar pattern to the timing of this development (Zerlin et al., 1995).
Gliogenesis, the birth of astrocytes and oligodendrocytes, is visible as early
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as embryonic day 12 in the developing CNS of rats, but the peak of
gliogenesis does not occur until the second postnatal week of
development (Hardy and Reynolds, 1991; LeVine and Goldman, 1988).
Because glial colonization of the cortex largely takes place after neuronal
migration, glia must be effectively integrated into the complex organization
of developing neuronal systems. The mechanisms for this to occur must
result in specific cellular interactions critical to neuronal and glial
functions. These interactions include cues for cell survival and axon
guidance; cell-cell contacts; myelin production by oligodendrocytes;
astrocyte process contacts with blood vessels, synaptic junctions, and
nodes of Ranvier (Zerlin and Goldman, 1997).
As astrocytes mature they induce the formation of a number of
functional barriers such as the blood brain barrier. Development of the
blood brain barrier begins during prenatal development (Wechslerr and
Meller, 1967). It consists of the abutting of blood vessel basal lamina with
astrocytic end feet to form a selectively permeable membrane. In 1997,
Zerlin and Goldman proposed that perhaps all astrocytic progenitors that
enter the cortex possess the same capability to contact vessels and may do
so randomly. In this model of astrocyte development from subventricular
cells, immature cells first migrate into the cortex along radial glial tracks.
The immature cells respond to local cues as they migrate, perhaps sampling
the environment with processes that come off tracks from time to time. The
initial contact between an immature migratory cell and a blood vessel is
random. They also suggest that blood vessels may provide signals that act
upon uncommitted progenitor cells to restrict their fates to an astrocytic
one. This hypothesis is supported by other data that suggest progenitor
cells can have various fates depending on the environment. The work of
2

Raff and colleges, 1983, with the O-2A progenitor cells clearly
demonstrated that a single progenitor cell could differentiate into multiple
cell types depending on environmental conditions. The determination of
astrocytic fate by cues released from endothelial cells may explain the time
frame of appearance and distribution of astrocytes and oligodendrocytes.
If the developmental fates of glial progenitors are driven in part by
growing blood vessels, then as the rates of vascular and pial surface
growth slow, astrogenic signals will decrease and progenitors will have an
increasing probability of developing along an oligodendrocyte pathway.
This would result in a gradual transition from astrocyte to oligodendrocyte
genesis. Also the number of astrocytes could provide an increasing source
of astrocyte-derived growth factors (Barres and Raff, 1996) that further
increase the probability of progenitors developing along an
oligodendrocytic pathway.
Astrocytes are also associated with the glia limitans and the
ependymal lining of the ventricular system. In addition, these cells regulate
the levels of ions and other active molecules in the extracellular space
which provide a homeostatic environment (Walz and Hertz, 1982; Ballanyi
et al., 1987). Some of these extracellular molecules, e.g. tenascin and
proteoglycans, play an integral role during the development of the
nervous system as a substrate for neuronal migration and axon elongation
(Silver et al., 1993; Rakic 1995). The molecules also establish functional
boundaries important for guiding developing neuronal connections.
Within the developing CNS, such boundaries are implicated in axonal
guidance in the diencephalon (Silver 1984), the optic chiasm (Navascues et
al., 1987; Silver et al., 1987), somatosensory barrel fields of the cortex
(Cooper and Steindler, 1986), the midbrain (Garcia-Abreu et al., 1995), and
3

the roof plate of the spinal cord and tectum (Wilkinson et al., 1987; Joosten
and Gribnau, 1989). These boundaries play an integral role in axon
guidance during embryogenesis by providing molecular cues that repel or
attract growing axons.
Maturation of astrocytes is reflected in the regulated expression of
specific proteins. Both protoplasmic astrocytes (found in the gray matter)
and fibrous astrocytes (found in the white matter) express vimentin early in
development and glial fibrillary acidic protein (GFAP) as they mature (Eng
et al., 1971; Bignami and Dahl, 1973; Dahl, 1981; Pixley and de Vellis, 1984;
Weir et al., 1984). The transition from an immature to a mature state is also
marked by the expression of specific glycoconjugates that may be
involved in pattern formation and the stabilization of neuronal contacts
(Steindler et al., 1990; Geisert and Bidanset, 1993). While the astrocytes
are forming a stable CNS environment, they acquire the potential to
become reactive and form a glial scar (Berry et al., 1983). Many
investigators believe that these reactive astrocytes contribute to the lack
of axonal regeneration in the mammalian CNS (Reier and Houle, 1988).
Oligodendrocytes are the last major cell type born in the brain. The
initial appearance of oligodendrocyte precursors appears to depend
crucially on spatial information present in the developing CNS.
Oligodendrocytes are derived from precursor cells that migrate from the
ventral regions of the neural tube (Jones and Westbrook, 1996). During
development, proliferating neuroepithelial cells of the spinal cord give rise
to the major classes of neurons. Oligodendrocytes develop from
precursors along the entire length of the spinal cord (Warf et al., 1991). In
1991, Warf and colleagues demonstrated that only precursors from the
ventral and not dorsal embryonic day 14 rat spinal cord gives rise to
4

oligodendrocytes. By embryonic day 18, both the dorsal and ventral
spinal cord has the capacity to generate these cells. This suggests that the
precursors migrate to the dorsal regions of the spinal cord. Other areas of
oligodendrocyte precursors include the optic nerve, midbrain, and
forebrain. A group of cells in the ventricular zone of the diencephalon of
the embryonic day 13 rat express mRNA for the platelet-derived growth
factor, which is a proliferation trigger for oligodendrocyte precursors
(Pringle et al., 1993). As these cells mature they migrate into the
developing thalamus and hypothalamus as well as more dorsal regions
including the cerebral cortex. Unlike neurons, oligodendrocytes continue
to proliferate and colonize areas of the CNS for several months after birth
in rats.
As oligodendrocytes mature they express many stage specific
antigenic markers. Oligodendrocyte progenitors express the ganglioside
GD3 (Goldman et al., 1984; Levi et al., 1987; LeVine and Goldman, 1988;
Hardy and Reynolds, 1991). As maturation proceeds, a transitional period
is entered when GD3 and galactocerebroside (GC) are coexpressed. As the
cells continue to develop, GD3 expression is lost and the expression of
proteins marking mature oligodendrocytes begin (Hardy and Reynolds,
1991; Miller, 1996). Oligodendrocytes are fully mature when they begin to
myelinate axons. The compact layers of membranes that form myelin
sheaths contain a number of unique components. Some components
associated with myelin are: GC (Raff et al., 1978; Raff et al., 1979),
nucleotide-3-phosphohydrolase (McMorris, 1983), myelin basic protein
(Reynolds and Wilkin, 1988), myelin-associated glycoproteins (Salzer et al.,
1990; Quarles et al., 1992), and myelin/oligodendrocyte glycoprotein
(Linington et al., 1984). Mature oligodendrocytes are essential for proper
5

CNS function and are believed to prohibit axonal sprouting and growth
(Caroni and Schwab, 1988).
Geisert and colleagues (1991a) recently identified a glial protein, the
rat target of the antiproliferative antibody (rTAPA), that is a member of the
tetramembrane spanning family. This family of proteins contains four
transmembrane domains with one major extracellular loop and intracellular
C- and N-terminal regions (Oren et al., 1990; Takahashi et al., 1990;
Virtaneva et al., 1993). All of these proteins (CD9, CD37, CD53, CD63,
TAPA-1, CO-029, R2, KAI1 and late bloomer) have considerable sequence
homology at the amino acid level (Jennings et al., 1990; Oren et al., 1990;
Kaprielian and Patterson, 1993; Yatomi et al., 1993; Dong et al., 1995;
Kaprielian et al., 1995; Kopczynski et al., 1996). The only other member
that has been found in the mammalian nervous system is CD9. It is
expressed by Schwann cells in the peripheral nervous system (Kaprielian
and Patterson, 1993) and appears to be expressed by oligodendrocytes in
the CNS (Deissler et al., 1996; Nakamura et al., 1996). As with other
members of this family, rTAPA appears to be associated with the formation
of stable cellular contacts. The focus of the present study is to define the
developmental regulation of rTAPA.
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CHAPTER 2. MATERIALS AND METHODS

Immunohistochemistry
Postnatal Sprague-Dawley rats of various ages were anesthetized
with a mixture of xylazine (13 mg/kg,Rompun®) and ketamine (87
mg/kg,Ketalar®) which was administered by intraperitoneal injection. The
animals were perfused through the heart with a solution of 0.1 M
phosphate buffered saline (PBS, pH 7.5) followed by 4%
paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.5). The brains and
spinal cords were removed and placed in 4% paraformaldehyde for 4
hours. For cryoprotection the tissues were placed in a 30% sucrose
solution and allowed to sink. The brains from older rats were sectioned at
50 um with a freezing microtome (American Optical Corporation, New
York). The brains from younger animals were cut at 50 um with a
vibratome (Technical Products International, St. Louis, MO) or 10 um with
a cryostat (Reichert Histostat, Buffalo, NY). Spinal cords were sectioned
with a freezing microtome (American Optical Corporation, New York). All
sections were stored in borate buffered saline (pH 8.4) at 4 OC.
To begin the immunohistochemical staining process, sections were
blocked for 2 hours at room temperature with 4% BSA (Sigma, St. Louis,
MO) in 0.2 M borate buffered saline (BBS, pH 8.4). Sections were then
placed in a solution containing the primary antibody at a concentration of
approximately 20 ug/ml in 0.2 M BBS with 1% BSA. They were
incubated in this solution overnight at 4 OC. Primary antibodies included
the AMP1 monoclonal antibody (directed against rTAPA) and a polyclonal
antibody directed against GFAP (Lipshaw, Pittsburgh, PA). Sections were
washed 3 times for 10 minutes in BBS, and then transferred to a solution
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containing the secondary antibody for 2 hours at room temperature. For
mouse monoclonal antibodies, a peroxidase-conjugated goat anti-mouse
IgG (Jackson Immuno Research Laboratories Inc., West Grove, PA) was
used at a dilution of 1:400 in BBS. For sections stained with rabbit
polyclonal antiserum, a peroxidase-conjugated donkey anti-rabbit IgG
(Jackson Immuno Research Laboratories Inc., West Grove, PA) was used at
a dilution of 1:400. The sections were rinsed in 2 changes of 0.2 M BBS,
followed by three rinses in 0.1 M PB (pH 7.2). Then the specimens were
incubated in a solution containing 1 mg/ml of 3, 3 diaminobenzidine
tetrahydrochloride (Sigma, St. Louis, MO) in 0.02 M PB (pH 7.4) and
5ul/ml of 3% hydrogen peroxide for 15-30 minutes at room temperature.

Gel Electrophoresis and Immunoblot Method
Adult Sprague-Dawley rats were anesthetized with a mixture of
xylazine (13 mg/kg,Rompun®) and ketamine (87 mg/kg,Ketalar®) and then
decapitated. The brain of each animal was removed and homogenized in 5
ml of 0.01 M PBS. Samples of different tissues were dissolved in nonreducing sample buffer (2% SDS, 10% glycerol in 0.05 M Tris-HCL buffer,
pH 6.8). These protein samples were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) using a 4 to 16% gradient
mini-gel, following procedures described previously (Geisert et al., 1991).
After electrophoresis, the proteins were transferred to nitrocellulose using a
Bio Rad mini-transblotter. Blots were then blocked in 5% non-fat dry
milk, probed with the AMP1 antibody, anti-GFAP antiserum (Lipshaw,
Pittsburgh, PA), or anti-myelin basic protein antiserum (Boheringer
Mannheim, Indianapolis, IN). Then the sections were rinsed in borate
buffer (pH 8.5), incubated in HRP-labeled secondary antibody and reacted
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with diaminobenzidine and hydrogen peroxide, as previously described
(Geisert and Bidanset, 1993). The level of immunoreaction product was
determined by scanning the blots and analyzing these scans with the NIH
Image Software. To define the relative levels of rTAPA expression,
quantification of proteins on immunoblots was conducted using a simple
limiting dilution approach. All samples were equilibrated to a set standard
using NIH Image Software. The samples were then diluted in two fold
increments and run on a 4 to 16% gradient gel and transferred to
nitrocellulose. Immunoblots were stained for rTAPA, using the AMP1
antibody. Blots were scanned into the imaging software using a
Macintosh computer with a high resolution desk top scanner (Hewlett
Pakard ScanJet II CX). NIH Image software was then used to compare the
intensity of the rTAPA immunolabeling to define the dilution factor that
produced a similar level of rTAPA immunoreactivity. All samples were
standardized to the adult (postnatal day 30 or older animal).

Cell Cultures
Glial cells were cultured from the cerebral cortex of SpragueDawley rat pups ranging in age from postnatal day 1 (P1) to postnatal day
5 (P5) using a protocol similar to that described in Giesert and Stewart
(1991). The animals were anesthetized by cold and decapitated.
Immediately following decapitation the brains were removed. The
meninges were stripped from the surface, and the cortices were placed in a
petri dish containing 10 mls of Hank’s Balanced Salt Solution (HBSS).
The tissue was placed in 20 mls of 0.1% trypsin in HBSS for 10 minutes.
Then mechanically dissociated and placed in 30 mls of medium containing
either 5% or 10% fetal calf serum in 75 cm2 flasks at a density of 5 x 103
9

cells/cm2. The flasks were then placed in an incubator at 37 OC with 5 %
CO2.
To define the distribution of rTAPA, the cells were stained using
immunohistochemical methods when the cultures were approximately 70%
confluent. The AMP1 antibody was detected with a fluorescein-labeled
Goat anti-mouse secondary (Jackson Immunolaboratories Inc., West Grove,
PA), to identify rTAPA expression. The cells were counterstained with
either a murine monoclonal IgM, directed against oligodendrocytes (Dyer
et al., 1991), or a rabbit antiserum directed against GFAP (Lipshaw,
Pittsburgh, PA), to identify astrocytes. To facilitate GFAP staining 1%
Triton X-100 was added to the BBS solution. Cultures were washed 3
times for 10 minutes in BBS and then transferred to a solution containing
the secondary antibody for 2 hours at room temperature. The secondary
antibodies, a rhodamine-conjugated Donkey anti-mouse IgM (Jackson
Immunolaboratories Inc., West Grove, PA) or a rhodamine-conjugated Goat
anti-rabbit IgG (Jackson Immunolaboratories Inc., West Grove, PA), were
used at a dilution of 1:500 in BBS. The cultures were rinsed 3 times for 10
minutes in BBS. The cultures were examined using a Leitz Laborlux D
microscope.

In Situ Hybridization
Three adult Sprague-Dawley rats were perfused as described above,
with the exception that all of the solutions were made with DEPC-treated
water. The brains were removed, placed in 30% sucrose, and sectioned at
20 um on a cryostat. Sections were mounted directly onto glass slides and
stored at -20 OC.
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RNA probes were made from a 500 base pair insert placed into the
Invitrogen pCR 2.1 vector. The insert encodes for bases 225-725 of the
rTAPA sequence (accession number U19894). Sense and anti-sense cRNA
probes were made using the Riboprobe kit from Promega. The probes
were synthesized from the linearized plasmid using the T7 and SP6
promoters respectively. The incorporation of digoxigenin (DIG)
conjugated UTP was approximately 1 DIG labeled to 4 unlabeled UTP.
Sections were removed from the freezer and placed at room
temperature for 30 minutes. Then they were submersed in chloroform for 2
minutes to extract the lipids and the chloroform was allowed to evaporate.
The sections were placed in a humidified chamber at 55 OC for 30 minutes.
The probe was prepared by adding 100 ul of the hybridization solution
(2X SSC, 10% dextran sulfate, 2mM EDTA, 50% deionized formamide, and
200 ug of sperm DNA) to 200 ng/ml of DIG-labeled probe. The mixture
was warmed to 95 OC for 4 minutes. Labeled probe was then added to the
sections and the solution was sealed by applying a coverslip. Care was
taken not to trap air under the coverslip. The sections were incubated at
70 OC for 4-6 hours. The coverslips were removed by soaking the slides in
2x SSC overnight at room temperature. The sections were rinsed 3 times at
55 OC with 50% deionized formamide in 1x SSC, 2 times in 1x SSC at room
temperature, and 5 times in TBS pH 7.5 at room temperature. The sections
were incubated in the Boerhinger Mannheim blocking solution
(Boerhinger Mannheim Indianapolis, IN) for 30 minutes at room
temperature. Then an anti-DIG antibody conjugated to alkaline
phosphatase (Boerhinger Mannheim Indianapolis, IN) was added to the
solution at a 1 to 400 dilution with 1% blocking solution in TBS pH 7.5
and incubated overnight at 4 OC. The sections were rinsed 4 times for 10
11

minutes each with TBS pH 7.5. The nitro blue tetrazolium chloride and 5bromo-4-chloro-3-indolylphosphate, toluidine-salt (NBT/BCIP) solution
was added to the sections and allowed to react for 8-16 hours in the dark
at room temperature.
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CHAPTER 3. RESULTS

In the present study the monoclonal antibody AMP1 was used to
define the levels and distribution of rTAPA (CD81). When protein
samples were denatured with SDS and presented on nitrocellulose, the
AMP1 antibody recognized two proteins. Both proteins were cloned and
sequenced (Geisert et al., 1996b). The 106 kDa antigen was alpha actinin
and the 27 kDa antigen was rTAPA. Although the AMP1 recognized
these two proteins when they are denatured and presented on
nitrocellulose, it only recognized rTAPA in formalin fixed tissue or in
cultured cells. This is supported by several different lines of evidence
(Geisert et al., 1996). Both alpha actinin and rTAPA are found in detergent
extracts of rat brain and primary cultures of rat glia; however, the AMP1
antibody will only immunoprecipitate rTAPA, not alpha actinin (Geisert et
al., 1996b). Furthermore, the AMP1 antibody recognizes alpha actinin on
immunoblots of protein from tissues it will not stain. For example on
immunoblots of C6 glioma, human glioma (U737), or human brain, the
AMP1 antibody recognizes a single protein at 106 kDa (our antibody does
not recognize human TAPA-1). When these glioma or sections of human
brain are stained using immunohistochemical methods no immunoreaction
product is observed (Data not shown), demonstrating that the antibody
can see alpha actinin on immunoblots but not in tissues. Taken together
these data demonstrate that the AMP1 antibody recognizes only rTAPA in
sections of the rat brain or in cultures of rat cells under the conditions that
we employed.
The relative levels and distribution of rTAPA in different tissues
were examined using immunoblot methods. Protein samples were taken
13

from a number of different rat tissues: liver, muscle, tendon, kidney, testicle,
cartilage, skin, sciatic nerve, and brain. These protein samples were
equilibrated and placed in non-reducing sample buffer. The highest levels
of rTAPA were found in the protein samples of brain, with detectable levels
observed in the protein samples of cartilage, testicle, and kidney (Fig. 1).
The remaining tissues had minimal levels of rTAPA, including the sample of
peripheral nerve (Fig. 1 lane G). The relative levels of rTAPA in the brain
and kidney were compared by a limiting dilution analysis. Approximately
equivalent levels of rTAPA were found when the full strength sample of
kidney proteins was compared to the sample of the brain diluted 1 to 64.
These data demonstrated the high levels of rTAPA in the brain,
especially in comparison to the other body tissues examined.

Developmental Regulation of rTAPA in the Brain
The developmental expression pattern of rTAPA in the developing
brain was quantified using immunoblot methods. To allow for the
quantitative immunoblot analysis of rTAPA, protein samples from different
developmental stages were made (Fig. 1 lanes A and B). Protein samples
were taken from embryonic day 18 (E18, the time of peak neuronal birth in
the cerebral cortex), postnatal day 1 (P1, near the end of neurogenesis and
the beginning of gliogenesis), P7 (a time near the peak of gliogenesis), P14
(a time of rapid glial maturation) and P30 (when the brain is relatively
mature). All samples were equilibrated and the levels of rTAPA within
each sample were determined by running samples of two different ages on
the same immunoblot. The levels of rTAPA observed in the adult samples
were set at 100% and three independent samples were taken at each time
point (Fig. 2). The levels of rTAPA observed at E18 and P0 were similar
14

Figure 1 Blots of protein samples from different rat tissues were stained
with the AMP1 antibody. Under non-reducing conditions, the AMP1
antibody recognizes two proteins when they are presented on
nitrocellulose: alpha actinin at 106 kDa and rTAPA at 26 kDa. Six
different rat protein samples are shown: E18 brain (A); adult brain (B);
dissected subcortical white matter from the adult (C); gray matter from the
adult cerebral cortex (D); a sample of cultured astrocytes (E); kidney (F);
and peripheral nerve (G). The total load of proteins in all lanes were
balanced. Notice that the levels of rTAPA in the adult brain are
considerably higher than that observed in the kidney, the embryonic brain,
and peripheral nerve. In addition, the levels of rTAPA in the white matter
are approximately equal to that found in the gray matter. Molecular
weight markers are indicated to the left in kilodaltons.
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and represented approximately 7% of the adult. The most dramatic
upregulation of rTAPA occurred in the second postnatal week, increasing
from 15% of adult at P7 to 70% by P14. Following P14 there was a
gradual increase until adult levels were reached.
Since the increase in the levels of rTAPA appeared to correlate with
the birth and maturation of glial cells, we examined the protein levels
associated with astrocyte and oligodendrocyte maturation. As astrocyte
mature there is a switch from the intermediate filament protein vimentin to
GFAP. Thus, these two proteins were used as markers for the maturation
of astrocytes. Immunoblots of protein samples from the developing brain
were probed with antibodies directed against GFAP and vimentin (Fig. 3).
As expected the levels of vimentin decreased as the levels of GFAP
increased. This increase in GFAP and decrease in vimentin occurs with
approximately the same time course as the upregulation of
rTAPA. The second major class of macroglia is the oligodendrocytes.
Myelin basic protein was used as a marker for mature oligodendrocytes
and myelin (Fig 3). The upregulation of myelin basic protein was delayed
relative to that of rTAPA. Myelin basic protein was not observed until
P14. A dramatic increase in the levels of myelin basic protein occurred
between P14 and P30. These immunoblot data indicate that rTAPA is
upregulated along a time course that is similar to that of other proteins
associated with glial maturation.

Cellular Distribution of rTAPA:
Our immunoblot analysis indicates that rTAPA is expressed during
the maturation of glia within the brain and that very low levels of the
protein are found before this developmental period. Two different
16

Figure 2 The levels of rTAPA at different developmental ages are shown.
Limiting dilutions of samples containing equivalent amounts of protein
were used to define the relative amounts of rTAPA, expressed as a
percentage of adult. Through postnatal day 7 the expression levels of
rTAPA remain low, under 15%. By postnatal day 14 a dramatic increase in
expression is seen with 70% of adult expression observed. The change in
expression between P7 and P14 is statistically different (Mann-Whitney U
test, p<0.05). Notice that the levels of rTAPA continue to increase even
after P30.
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Figure 3 The developmental regulation of specific astrocyte and
oligodendrocyte marker proteins were examined using immunoblot
analysis. Whole brain protein samples of P0 (lanes A, C, and E) and P30
(lanes B, D, and F) rats were blotted and probed with antibodies to GFAP
(lanes A and B), vimentin (lanes C and D), and myelin basic protein (lanes
E and F). The expression of GFAP is dramatically upregulated from P0 to
P30, while vimentin expression is greatly reduced. Myelin basic protein
shows no expression at P0 but is highly expressed at P30. approaches
were taken to define the cells within the brain that express this protein.
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The first was to examine cultured cells using immunohistochemical
methods and the second was to use in situ hybridization to define the cells
containing the messanger ribonucleic acid for rTAPA. Neurons and glia
were cultured from the developing rat CNS and stained by
immunohistochemical methods using the AMP1 antibody. The cell
cultures were counterstained to define astrocytes (using anti-GFAP
antiserum), oligodendrocytes (using the CE1 monoclonal antibody) or
neurons (using the TuJ1 antibody). AMP1 stained astrocytes and
oligodendrocytes (Fig. 4). The rTAPA immunoreaction product was seen
primarily at points of cell-cell contact for both type 1 astrocytes and type 2
astrocytes. Oligodendrocytes were more intensely stained by AMP1 than
astrocytes. High density staining was seen throughout the cells, with
staining extending to the tips of all processes. AMP1 immunostaining was
not seen on the TuJ1 positive neurons (data not shown). These data
demonstrated that both cultured astrocytes and cultured oligodendrocytes
express rTAPA.

In Situ Hybridization
One approach to defining the cells within the adult brain that
express rTAPA is to use in situ hybridization. Figure 5 illustrates the
pattern of labeling in the hippocampus following hybridization with the
sense probe (Fig 5A and 5C) and the antisense probe (Fig. 5B and 5D).
When comparing the antisense labeling to the sense labeling a clear
pattern of cellular labeling is observed. The most dramatic difference is in
the many small cell bodies throughout the sections labeled with the
antisense probe. In addition, the choroid plexus is heavily labeled along
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Figure 4 The pattern of AMP1 labeling is illustrated in photomicrographs
of mixed glial cultures. The cultures were stained with AMP1 (A and C).
Panel A and B are taken from the same culture, counterstained with antiGFAP (B), to mark astrocytes. Panel C and D are taken from the same
culture, counterstained with the CE1 antibody (D), to mark
oligodendrocytes. The AMP1 antibody labels the external surface of both
astrocytes and oligodendrocytes. All photomicrographs taken at the same
magnification. Scale bar = 50 µm.
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Figure 5 The cells expressing rTAPA mRNA are illustrated by using in situ
hybridization. A and B are low magnification photomicrographs of the
hippocampus from adjacent sections of the adult rat brain. C and D are
higher magnification photomicrographs taken from the CA3/alveus region.
The section illustrated in A and C was probed with the sense riboprobe
and the section in B and D were labeled with the antisense riboprobe. At
the low magnification, the general pattern of labeling can be observed.
Notice that the choroid plexus and ependymal lining of the ventricles are
heavily labeled. At a high magnification, many cell bodies are labeled with
the antisense probe and there is a lack of labeling in the pyramidal cell
layer. The Scale bar in C = 100 um.
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with the ependymal lining of the ventricles. A closer examination of the
tissues reveals that the large pyramidal cells of the hippocampus are not
labeled (Fig. 5B and 5D). In these sections, no labeling of large identifiable
neurons was observed. The labeling of small cell bodies within the gray
matter and white matter is consistent with the expression of rTAPA by glia
within the CNS.

Distribution of rTAPA in the Developing Brain
To define the distribution of rTAPA during the development of the
CNS, we examined sections through the brain using indirect
immunohistochemical methods. This analysis included coronal sections
from a variety of developmental stages: E18, P0, P7, P14, P30 and adult. In
the E18 brain, low levels of the AMP1 immunoreaction product were
observed within the parenchyma of the brain, with virtually no labeling of
the neocortex or neostriatum (data not shown). The most notable
accumulation of immunoreaction product was observed in the choroid
plexus and the ependymal lining of the ventricular system. There was also
a pronounced labeling of the glia limitans. AMP1 labeling patterns in the
P0 brain are illustrated in figure 6B. Since the blood brain barrier is not
formed at this age it was important to compare the pattern and intensity of
labelling observed in the AMP1 stained sections to those found in similar
control sections treated in an identical manner with the exception that the
primary antibody was omitted from the staining protocol. The secondary
antibody was preabsorbed against rat IgG, and the immunoreaction
product in the control section was minimal (Fig. 6A). There was a modest
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Figure 6 The distribution of AMP1 immunoreactivity in the rat brain is
illustrated at three different developmental ages. A and B are sections from
a P0 rat brain. C is a section from a P14 rat brain. D is a coronal section
from an adult brain. A is a control section stained in a manner identical to
that of B with the exception that the primary antibody was omitted.
Notice that there is minimal staining with the secondary antibody alone. In
B the immunolabeling pattern of the AMP1 antibody is shown. The most
dramatic labeling is seen in the choroid plexus and glial limitans. As the
brain matures the levels of immunoreactivity are dramatically upregulated,
as can be seen in the section from the P14 brain (C). The highest levels are
found in the adult (D). All photomicrographs are taken at the same
magnification. The scale bar in D = 500 µm.
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amount of labeling at the edge of the section and in the choroid plexus.
When the section stained with the AMP1 antibody was compared to this
control section, a substantial amount of antibody-specific staining was
observed. The most heavily labeled structures were the choroid plexus
and the ependymal cells lining the lateral ventricle. Relatively high AMP1
immunoreactivity was also observed at the glia limitans. This labeling
appeared to be specific to the AMP1 antibody since the individual cellular
processes could be observed and this type of labeling was not seen in the
control section. Along with these high levels of reaction product, there
was also a modest amount of diffuse labeling in the parenchyma of the
brain. The levels of AMP1 immunoreactivity in the parenchyma slowly
increased over the next several weeks.
Although the overall levels of AMP1 immunoreactivity increased
between P7 and P14, the general pattern of expression was similar.
Therefore, only the AMP1 immunoreactivity observed at P14 is
illustrated(Fig. 6C). In sections stained with the AMP1 antibody, there
was an increase in immunoreactivity throughout the brain during this
period. The highest density of staining was seen in the glial limitans,
choroid plexus, and ependymal lining of the ventricular system. In these
structures there were indications that rTAPA was concentrated at specific
regions of the cells. The best example of this was the choroid plexus. At
high magnifications, immunoreaction product was concentrated at regions
of cell-cell contact (Fig. 7A), reminiscent of the staining pattern observed
in confluent cultures of type 1 astrocytes. This labeling outlined the
individual choroidal cells giving the appearance of a tiled mosaic. A similar
type of cellular distribution and patterning was also seen in the ependymal
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Figure 7 The pattern of immunolabeling in the choroid plexus (A) and the
junction between white and gray matter (B) can be seen in these high
magnification photomicrographs taken from the P14 brain. The choroid
plexus illustrates the high levels of rTAPA immunoreactivity at the sites of
cell-cell contact. Note the difference in the staining pattern at the junction
between the white and gray matter, along with the staining of small cell
bodies with AMP1 (B). Both photomicrographs are taken at the same
magnifications (Scale bar in B = 50 µm).
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lining of the ventricular system (data not shown). Finally, an increase in
immunoreactivity was observed surrounding all blood vessels (Fig. 7B). In
these young animals, immunoreaction product outlined small cell bodies in
the gray and white matter.

Distribution of rTAPA in the Adult Brain
When tissue sections of the adult brain were stained with the AMP1
antibody, a reticulated pattern of labeling was seen throughout the tissue,
with clear evidence of specific concentrations of immunoreaction product
(Fig. 6D). The regions with elevated levels of immunolabel were all
associated with glial structures. At the glia limitans, there was an elevation
of labeling just beneath the pial surface. High levels of AMP1 labeling
were also observed at the ventricular surface, where rTAPA was seen to
concentrate at regions of cellular contact between and beneath the
ependymal cells. Similar to the ependyma, the choroid plexus also
displayed intense AMP1 immunoreactivity. If the choroidal
cells were examined face on, the pattern of labeling exquisitely marked the
junctional regions between cells, leaving a mosaic pattern of staining. In
the gray and white matter of the adult brain it was difficult to identify the
types of cells carrying the immunoreaction product. In the gray matter a
dense irregular reticulated pattern of labeling was seen with little
indication of neuronal labeling. The pattern observed in the white matter
differed, with a regular linear array to the staining pattern. The orientation
of this linear array mimicked the direction of axonal pathways within the
section of white matter. The pattern of labeling in the adult brain was
consistent with a generalized staining of glial processes.
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When sections through the adult spinal cord were stained with
AMP1 (Fig. 8C), the general pattern of immunoreactivity was similar to that
observed in sections stained with the astrocyte marker GFAP (Fig. 8A).
The intensity of labeling in the gray matter was heavier than that of the
white matter where bundles of axons were running up and down the
spinal cord. Similar to the brain, there was a general increase in labeling at
the glial limitans. There were also elevated levels of GFAP and AMP1
immunoreactivity around the central canal. The most intriguing similarity
between these two sections was the staining of the trabecular network of
astrocytic processes by GFAP and the similarly stained pattern in the
AMP1 sections. This was particularly evident at high magnifications,
where the pattern of GFAP-positive processes (Fig. 8B) was very similar to
that found in the AMP1 stained section (Fig. 8D).
Interestingly, there were no indications that compact myelin was
labeled with AMP1 antibody in these sections of the spinal cord. This
appeared to contradict data from tissue culture studies, where the AMP1
antibody stained both astrocytes and oligodendrocytes. To provide an
independent means of assessing the distribution of rTAPA, samples of total
brain, gray matter, white matter and myelin were analyzed using a
quantitative immunoblot method. This approach revealed that rTAPA was
found at approximately equal levels in gray matter, white matter and
myelin (Fig. 3). Therefore, rTAPA is in compact myelin and appears to be
expressed by all glial cells. Although there are a number of possible
explanations for the lack of immunostaining of compact myelin, the most
likely explanation is that the extracellular epitope is hidden within the
wraps of compact myelin.
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Figure 8 The distribution of AMP1 immunoreactivity in the adult spinal
cord is illustrated in a series of low and high magnification
photomicrographs. High levels of AMP1 immunoreactivity (C and D) are
observed in the spinal cord. In a similar section stained for GFAP (A and
B), the distribution of astrocytes in the spinal cord is illustrated. As in
cortex, the AMP1 immunoreactivity in white matter is lower than gray
matter (C). Note the similarity in the staining patterns between the antiGFAP and AMP1 stained sections. A and C are at the same magnification
and B and D are higher magnification photomicrographs (Scale bar in D =
25 µm).
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CHAPTER 4. DISCUSSION

The present study examines the expression of rTAPA in the
developing rat brain and spinal cord. The immunoblot analysis reveals
three distinct phases in regulation of rTAPA within the brain. Before the
second postnatal week the levels of rTAPA are relatively low. Then there
is a dramatic upregulation of the protein during the second postnatal
week. During the last phase, the levels of rTAPA continue to increase
gradually until adult levels are reached. In addition to the overall change
in the levels of rTAPA, there is a striking alteration in the distribution of the
protein. The relatively low levels of rTAPA observed in the embryonic
brain are associated with the glial limitans, the ependymal lining of the
ventricular system, and the choroid plexus. This pattern of rTAPA
expression remains relatively constant from E18 through the first postnatal
week. During this developmental period most of the neurons within the
brain are born and are entering their final stages of development (Berry
and Rogers, 1965). The low levels of rTAPA and the lack of detectable
neuronal labeling in the brain or spinal cord demonstrates that rTAPA is
not directly involved in this phase of neuronal development. The labeling
observed at the glia limitans, the ependymal lining of the ventricle and the
choroid plexus, indicates that rTAPA is specifically involved with these
glial cells.
During the second postnatal week there is a dramatic increase in the
overall levels of rTAPA. The relative levels go from 15% of adult at P7 to
70% of the adult level by P14. As observed at earlier stages of
development, the ependymal cells, the choroid plexus and glial limitans are
labeled by the antibody. The predominant change in the distribution of
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the protein occurs within the parenchyma of the brain and spinal cord. A
fine reticulated pattern of immunoreaction product is found through the
tissue with labeling of small cell bodies. The labeling of these small cell
bodies may reflect the birth and maturation of glia. The maturation of
these glial cells makes the second postnatal week a very interesting
developmental period, characterized by dramatic changes in proteins
related to the glial environment. One indicative change in maturing
astrocytes is a change in intermediate filament proteins. The cells
downregulate vimentin as GFAP expression increases (Dahl, 1981). It is
also during this period that astrocytes acquire the ability to become
reactive and to form a glial scar. It is during this period that
oligodendrocytes are also born and begin to form myelin.
Oligodendrocytes express a number of unique and well characterized
proteins involved in the formation of myelin (Raff et al., 1978; Raff et al.,
1979; Reynolds and Wilkin, 1988; Hardy and Reynolds, 1991; Miller,
1996). One of these proteins, myelin basic protein, is expressed by mature
oligodendrocytes and compact myelin. We have found that rTAPA levels
increase dramatically at a time when both astrocytes and oligodendrocytes
are born and begin to mature. These data indicate that rTAPA
upregulation is associated with these cell types. This is supported by the
evidence from tissue culture, where both astrocytes and oligodendrocytes
are labeled by the AMP1 antibody.
After the second postnatal week there is a gradual increase in the
levels of rTAPA. During this period the levels of rTAPA within the
parenchyma of the brain appear to increase. In white matter tracts a fine
linear array of immunolabeling is observed and there is very little indication
of staining within compact myelin. One of the key developmental events
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occurring during these last phases of development is the myelination of
axons by oligodendrocytes. Since immunoreactivity in compact myelin
was not observed, biochemical methods were used to asses the levels of
rTAPA in myelin sheaths. This analysis of myelin isolated from adult brain
demonstrated that rTAPA is present in myelin at levels equivalent to that of
the white matter or gray matter. To address the time frame of rTAPA
expression relative to myelin production, the temporal expression of myelin
basic protein was defined. At P7 myelin basic protein was not detectable
by immunoblot methods, and only moderate levels were observed by P14.
At the next time point examined, P30, near adult levels were observed.
These results are consistent with the observations of Hardy and Reynolds
(1991) and LeVine and Goldman (1988), who found mature
oligodendrocytes around P10 but very few at P7. The gradual increase in
rTAPA expression in the later phases of development appears to be
attributed to the late maturation of oligodendrocytes and compact myelin.

Cells Expressing rTAPA
Within the brain and spinal cord a variety of cell types express
rTAPA. The first cells to express it are ependymal cells and choroidal cells.
These cells are clearly labeled at E18 and remain labeled in the adult
animal. The dramatic upregulation of rTAPA during the second postnatal
week appears to be associated with the expression of this protein by
astrocytes and oligodendrocytes. This is substantiated by tissue culture
experiments in which both astrocytes and oligodendrocytes were labeled
by an antibody directed against rTAPA. The last major class of glia are
microglia (Flaris et al., 1993). Finally, the potential expression of rTAPA by
neurons is more difficult to assess. In the embryonic and early postnatal
32

brain, neurons do not appear to express rTAPA, for there is no labeling of
the parenchyma of the brain. Once the fine reticulated pattern of labeling
appears in the gray and white matter, it is very difficult to define which of
the cell types are labeled by the AMP1 antibody. To determine if neurons
in the adult brain express rTAPA, in situ hybridization was used. In these
experiments the only cells that were labeled by the antisense rTAPA probe
had small cell bodies and no clear neuronal labeling was observed. This
lack of neuronal labeling was particularly clear for the pyramidal cells of
the hippocampus and the cerebral cortex, where the large cell bodies could
be seen and these cells were not labeled. Even though neuronal labeling
was not observed, the possibility that some population of neurons
expresses rTAPA cannot be excluded. Taken together these data
demonstrate that rTAPA is expressed by glial cells during a postnatal
period of astrocyte and oligodendrocyte maturation.

Astrocyte Maturation
Astrocytes have many different functional roles in the CNS. During
the development of the brain and spinal cord, astrocytes are involved in
the migration of neurons from germinal zones to their final locations
(Hatten, 1990; Anton et al., 1996). In addition, interactions between
astrocytes and growth cones are thought to be critical to the formation of
neuronal pathways (Silver and Rutishauser, 1984). Later in development,
specific sets of astrocytes in boundary regions express proteins believed to
separate functional units of the CNS (Steindler et al., 1990; Geisert and
Bidanset, 1993). As development continues, astrocytes appear to take
over a role of maintaining a homeostatic environment within the CNS and
forming protective barriers (Walz and Hertz, 1982; Ballanyi et al., 1987).
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Astrocytic endfeet at the edge of the brain provide one of the key
structural components of the glial limitans. Astrocyte contact with
endothelial cells induces the formation of the blood-brain barrier.
Astrocytes aid in the regulation of ionic and molecular compounds in the
extracellular fluids through specific uptake mechanisms. The astrocytic
barriers are located at each point of contact between the CNS and the
outside world. In addition, during the final stages of development,
astrocytes are believed to be directly involved in stabilization of CNS
structure and synaptic connectivity patterns. It is during this final stage of
development that astrocytes acquire the ability to respond to injury and
become reactive (Berry et al., 1983) and aquire macrophage-like features
(Fontana et al., 1984; Takiguchi and Frelinger, 1986). Part of the response
to injury may be the expression of major histocompatibility II proteins
which can associate with human TAPA-1 in the plane of the cell membrane
(Secrist et al., 1996). During this period of development there is a tight
correlation between upregulation of rTAPA at the site of injury and the
ability of astrocytes to become reactive as judged by GFAP staining
(Geisert, personal observation).

Role of rTAPA
In several cases the molecular interactions of the tetramembrane
spanning family members have been defined. Some family members
interact with traditional adhesion molecules. For example, CD9 is
associated with ß1 integrins (Slupsky et al., 1989; Masellis-Smith and
Shaw, 1994). On the other hand, some of the tetramembrane spanning
family members are associated with either kinase or phosphatase activity.
These associations appear to link cell adhesion to second messenger
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systems. These molecular cascades affect cell behaviors such as mitotic
activity and cell adhesion (Nakamura et al., 1995). For example, during
platelet activation (Jennings et al., 1990; Yatomi et al., 1993) there is an
increase in phosphorylation that can be replicated by the binding of the
CD9 antibody. Similar effects are observed with TAPA-1, where antibody
binding activates a tyrosine kinase (Schick et al., 1993). Finally, late
bloomer appears to be associated with adhesion at the neuromuscular
junction and phosphatase activity (Kopczynski et al., 1996).
Like other members of this family of proteins, an analysis of the
deduced structure of rTAPA (fig. 9) reveals that a large part of the
molecule is found within the cell membrane, with four transmembrane
domains accounting for approximately 40% of the structure. It also
exhibits a large and small extracellular loop. Assuming that the cystines at
amino acid 156 and 190 of the large extracellular loop are linked by a
disulfide bond, both loops would be closely associated with the cell
membrane. Furthermore, based on a secondary structural analysis using
predictions from Chou and Fasman, 1974, and Garnier et al., 1978, the loop
forms an alpha helix. Since each amino acid in an alpha helix represents a
distance of 1.5 Å, the maximum distance the large loop can extend from the
surface of the cell is 40.5 Å. Even if no disulfide bonds are formed the
maximum distance the second loop can extend from the surface of the cell
is 64.5 Å. Based on X-ray crystallographic studies of N-cadherin (Shapiro
et al., 1995), a cell adhesion molecule, the extracellular space is
approximately 290 Å from membrane to membrane. Thus, the two
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Figure 9 The structure of rTAPA is illustrated in the upper portion of the
figure. It possesses a large and small extracellular loop, with intracellular
amino and carboxy termini. Notice that the large extracellular loop has
four cystines which may form disulfide bonds sensitive to reducing
reagents. This may explain the destruction of the AMP1 epitope following
sample reduction. In addition to this model of rTAPA, the deduced amino
acid sequence of the protein is shown. The membrane spanning regions
were defined using hydrophobicity analysis and these portions of the
protein are underlined.
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extracellular domains of the molecule appear to be too small for direct
interactions across the extracellular space.
Antibodies directed against the human hematolymphoid cell protein
TAPA-1 cause an increase in adhesion between these lymphoid cells and a
depression in their mitotic activity (Oren et al., 1990), suggesting this type
of cell behavior regulation is a common theme for members of the
tetramembrane spanning family of proteins. For example, antibodies
binding to CD9 enhance cell-cell adhesion (Forsyth, 1991; Masellis-Smith
and Shaw, 1994) and can decrease the mobility and invasiveness of tumor
cells (Miyake et al., 1991). Another family member, KAI1, is the metastatic
suppressor for prostate cancer (Dong et al., 1995). Without this protein
prostate cells cannot form stable cell contacts and are more capable of
metastatic behavior. When the levels of KAI1 are elevated by gene
transfection, there is a dramatic decrease in the metastatic behavior of these
cells. This theme of stabilizing cellular contacts is also demonstrated by the
most recently identified member of the tetramembrane spanning family, late
bloomer (Kopczynski et al., 1996). The late bloomer protein is involved in
stabilizing the synaptic contact between motor neurons and muscles.
Without this protein the growing axon does not appear to be capable of
docking with the muscle fiber. Thus, some members of the tetramembrane
spanning family are intimately involved in the formation and maintenance
of stable cell contacts, and rTAPA appears to play a similar role in glial
cells.

Conclusion
There is a general increase in the levels of rTAPA as glial cells are
born and mature. This increase in the overall levels of rTAPA is
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demonstrated by our immunoblot analysis; however, this type of analysis
could not reveal the cellular localization of rTAPA. Sections from the
developing brain stained for rTAPA, reveal a clear sequence of cellular
labeling. The cells of the ependyma and choroid plexus are the first to
express rTAPA, followed by astrocytes and oligodendrocytes. The general
increase in rTAPA expression occurs during the second postnatal week, a
pivotal point in development,. During this week, astrocytes and
oligodendrocytes begin to mature, the structure of the CNS is stabilized,
and astrocytes acquire the ability to become reactive. It is during this
period that the largest increase in rTAPA is observed, going from 15% to
70% of the adult (a five fold increase). To date, all identified members of
the tetramembrane spanning family play a role in the molecular cascade
leading to the stabilization of cellular contacts. These results, along with
family characteristics, indicate a possible role for rTAPA in the stablization
of the CNS.
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